Sisi Lin

Sisi Lin

Auto-generated profile, based on publicly available information

Sisi Lin

Department of Biopharmaceutics, Zhejiang Provincial Engineering Research Center of New Technologies and Applications for Targeted Therapy of Major Diseases, College of Life Science and Medicine Zhejiang Sci‐Tech University Hangzhou China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2025 in The FASEB Journal
Verified
Journal Article
Open access
MDMuhammad Dilawar
Muhammad Dilawar
XYXuan Yu
Xuan Yu
YJYuanyuan Jin
Yuanyuan Jin
JYJing Yang
Jing Yang
SLSisi Lin
Sisi Lin
GCGUIQIAN CHEN
GUIQIAN CHEN
The skeletal system provides vital importance to support organ development and functions. The Notch signaling pathway possesses well‐established functions in organ development and cellular homeostasis. The Notch signaling pathway comprises five typical ligands ( JAG1 , JAG2, DLL1, DLL3, and DLL4), four receptors ( Notch 1‐4), and four intracellular domains (NICD1‐4). Each component of the Notch signaling pathway has been demonstrated to be fundamental in osteoblast differentiation and bone formation. The dysregulation in the Notch signaling pathway is highly linked with skeletal disorders or diseases at the developmental and postnatal stages. Recent studies have highlighted the importance of the elements of the Notch signaling pathway in the skeletal system, as well as its interaction with signaling, such as Wnt/β‐catenin, BMP, TGF‐β, FGF, autophagy, and hedgehog (Hh) to construct a potential gene regulatory network to orchestrate osteogenesis and ossification. Our review has provided a comprehensive summary of the Notch signaling pathway in the skeletal system, as well as the insights targeting Notch signaling for innovative potential drug discovery targets or therapeutic interventions to treat bone disorders, such as osteoporosis and osteoarthritis. An in‐depth molecular mechanistic strategy to modulate the Notch signaling pathway and its associated signaling pathway will be encouraged for consideration to trigger enhanced therapeutic approaches for bone disorders by defining Notch‐regulating drugs for clinical use.

25 February 2025 in The FASEB Journal
Verified
Journal Article
Closed access
CZChenggong Zheng
Chenggong Zheng
CZChenyang Zhang
Chenyang Zhang
YHYiliang He
Yiliang He
SLSisi Lin
Sisi Lin
ZZZhenya Zhu
Zhenya Zhu
GCGUIQIAN CHEN
GUIQIAN CHEN